thromboDx BV is a molecular diagnostics company that develops and commercializes blood-based diagnostics through its proprietary platelet-powered technology platform and has its offices in Amsterdam, The Netherlands. The technology platform addresses the need for an easily accessible, minimally invasive source for high quality disease-specific nucleic acids in several markets.
thromboDx BV is managed by a dedicated team of professionals who are highly committed
A scientific advisory board will be announced in Q3-2013
thromboDx BV focuses on the development of molecular diagnostic tests. We combine in-house development of diagnostic tests in areas and indications of strategic interest with a licensing model for non-core areas. To enable this commercial model the company demonstrates applicability, technological and clinical robustness of the platform in validation cohorts. We seek partners for co-development and commercialization.